Elevance Health Inc (ELV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,741,000 | 4,937,000 | 3,934,000 | 3,609,000 | 4,075,300 |
| Marketable Securities | 24,992,000 | 20,685,000 | 18,810,000 | 21,448,000 | 19,727,200 |
| Receivables | 10,958,000 | 10,391,000 | 9,311,000 | 8,794,000 | 8,566,100 |
| Other current assets | 4,060,000 | 3,020,000 | 2,266,000 | 2,412,000 | 1,946,300 |
| TOTAL | $45,751,000 | $39,033,000 | $34,321,000 | $36,263,000 | $34,314,900 |
| Non-Current Assets | |||||
| PPE Net | 3,483,000 | 3,133,000 | 2,735,000 | 2,175,000 | 1,977,900 |
| Investments And Advances | 4,847,000 | 4,763,000 | 4,246,000 | 3,938,000 | 2,796,300 |
| Intangibles | 31,096,000 | 29,174,000 | 29,511,000 | 27,599,000 | 25,526,100 |
| Other Non-Current Assets | 1,438,000 | 1,350,000 | 758,000 | 565,000 | 467,900 |
| TOTAL | $40,864,000 | $38,420,000 | $37,250,000 | $34,277,000 | $30,768,200 |
| Total Assets | $86,615,000 | $77,453,000 | $71,571,000 | $70,540,000 | $65,083,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 700,000 | 1,598,000 | 849,000 | 1,275,000 | 928,400 |
| Accounts payable and accrued liabilities | 21,442,000 | 16,090,000 | 15,275,000 | 16,149,000 | 14,293,900 |
| Other current liabilities | 6,052,000 | 4,127,000 | 3,190,000 | 3,343,000 | 3,581,300 |
| TOTAL | $29,453,000 | $23,532,000 | $21,965,000 | $23,356,000 | $21,294,400 |
| Non-Current Liabilities | |||||
| Long Term Debt | 19,335,000 | 17,787,000 | 17,217,000 | 17,382,000 | 14,358,500 |
| Deferred Revenues | 1,259,000 | 1,017,000 | 902,000 | 860,000 | 971,900 |
| Other Non-Current Liabilities | 2,609,000 | 2,179,000 | 1,888,000 | 1,572,000 | 1,549,900 |
| TOTAL | $23,963,000 | $22,193,000 | $21,065,000 | $20,681,000 | $18,688,300 |
| Total Liabilities | $53,416,000 | $45,725,000 | $43,030,000 | $44,037,000 | $39,982,700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 244,906 | 252,330 | 257,012 | 255,722 | 264,379 |
| Common Shares | 3,000 | 3,000 | 3,000 | 3,000 | 2,600 |
| Retained earnings | 23,802,000 | 22,573,000 | 19,988,000 | 18,054,000 | 16,560,600 |
| Other shareholders' equity | 150,000 | -296,000 | -986,000 | -101,000 | -267,900 |
| TOTAL | $33,199,000 | $31,728,000 | $28,541,000 | $26,503,000 | $25,100,400 |
| Total Liabilities And Equity | $86,615,000 | $77,453,000 | $71,571,000 | $70,540,000 | $65,083,100 |